RNXT (STOCKS)
RenovoRx, Inc. Common Stock
$0.885800
+0.042000 (+4.98%)
Prev close: $0.843800
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Shaun R. Bagai
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $40.34M
- Employees
- 10
- P/E (TTM)
- -2.67
- P/B (TTM)
- 3.37
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.09 | $-0.08 | -0.0084 | -10.29% |
|
Dec 2025 (Q4)
|
$-0.08 | $-0.08 | +0.0016 | +1.96% |
|
Sep 2025 (Q3)
|
$-0.08 | $-0.08 | +0.0016 | +1.96% |
|
Jun 2025 (Q2)
|
$-0.08 | $-0.09 | +0.0067 | +7.73% |
Financial Statements
| Revenues | $1.58M |
| Benefits Costs and Expenses | $9.77M |
| Cost Of Revenue | $317.00K |
| Costs And Expenses | $13.11M |
| Gross Profit | $1.17M |
| Nonoperating Income/Loss | $600.00K |
| Operating Expenses | $14.04M |
| Selling, General, and Administrative Expenses | $8.20M |
| Research and Development | $5.84M |
| Operating Income/Loss | -$12.87M |
| Income/Loss From Continuing Operations After Tax | -$12.27M |
| Income/Loss From Continuing Operations Before Tax | -$8.18M |
| Income Tax Expense/Benefit | $2.00K |
| Net Income/Loss | -$12.27M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$12.27M |
| Net Income/Loss Available To Common Stockholders, Basic | -$12.27M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.33 |
| Diluted Earnings Per Share | -$0.33 |
| Basic Average Shares | 111,696,250 |
| Diluted Average Shares | 111,696,250 |
| Assets | $13.96M |
| Current Assets | $13.72M |
| Inventory | $379.00K |
| Prepaid Expenses | $501.00K |
| Other Current Assets | $12.84M |
| Noncurrent Assets | $244.00K |
| Fixed Assets | $77.00K |
| Other Non-current Assets | $167.00K |
| Liabilities | $2.70M |
| Current Liabilities | $1.92M |
| Accounts Payable | $1.12M |
| Other Current Liabilities | $801.00K |
| Noncurrent Liabilities | $779.00K |
| Equity | $11.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $11.27M |
| Liabilities And Equity | $13.96M |
| Net Cash Flow From Operating Activities | -$11.30M |
| Net Cash Flow From Operating Activities, Continuing | -$11.30M |
| Net Cash Flow From Investing Activities | -$5.34M |
| Net Cash Flow From Investing Activities, Continuing | -$5.34M |
| Net Cash Flow From Financing Activities | $9.08M |
| Net Cash Flow From Financing Activities, Continuing | $9.08M |
| Net Cash Flow | -$7.56M |
| Net Cash Flow, Continuing | -$7.56M |
| Comprehensive Income/Loss | -$12.27M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$12.27M |
| Other Comprehensive Income/Loss | -$14.69M |